arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Disc Medicine, Inc.

IRON Health Care Biotechnology: Pharmaceutical Preparations
$79.23
Today
as of Sep 4, 16:50 ET
Last 30 days +6.14% Jul 28 → Sep 04
$72.95 $75.56 $78.17 $80.78 $83.39 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$78.14
High
$80.01
Low
$78.14
Volume
$204,219
Avg Vol
$558,734
Mkt Cap
$3.1B
P/E (TTM)
—
Beta
—
52w High
$99.50
52w Low
$40.00
Div Yield
—
Shares Out
$38M

Recent Press Releases & News last 60 days · 8 items

Sep 2 · 12:00 PR GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences
Sep 2 · 11:03 MT Newswires
Wedbush Raises Price Target on Disc Medicine to $100 From $88, Keeps Outperform Rating
Aug 31 · 22:00 PR GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
▸ Show all 8 press releases & news Free account →

Overview

52-week range
$40
$100
66% of range
Avg surprise (last 3)
-14.8%
Avg reaction (last 2)
+1.1%
50% positive
Latest IV / EM
59%
EM ±9.2% · $80 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.77$-1.47$-1.18$-0.88$-0.58 Actual $-1.20Actual $-0.74Actual $-0.58Actual $-1.09Actual $-1.03Actual $-0.89Actual $-1.02Est $-0.99Actual $-1.58Est $-1.17Actual $-1.77Actual $-1.65Est $-1.55Actual $-1.54 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-64M$-55M$-46M$-37M$-28M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.54 — — — — financials
Tue May 5, 2026Mar/2026 $-1.65 $-1.55 -6.5% -61.8% -0.1% earnings
Tue Sep 30, 2025Sep 2025 $-1.77 — — — — financials
Thu Aug 7, 2025Jun/2025 $-1.58 $-1.17 -35.0% — — earnings
Wed May 7, 2025Mar/2025 $-1.02 $-0.99 -3.0% — +2.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.89 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.03 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.09 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.58 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.74 — — — — financials
Fri Mar 31, 2023Mar 2023 $-1.20 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-65M$-70M—$-68M$-61M$-40M—$-33M
Net income$-60M$-64M—$-62M$-55M$-34M—$-27M
EPS (diluted)$-1.54$-1.65—$-1.77$-1.58$-1.02—$-0.89

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$99M$89M$91M$141M$127M$123M$192M$193M
Inventory————————
Total current assets$733M$747M$804M$627M$662M$706M$494M$493M
Total assets$735M$750M$807M$630M$665M$709M$497M$495M
Long-term debt$59M$29M$29M$29M$29M$29M$28M—
Total liabilities$91M$62M$67M$57M$51M$49M$53M$27M
Total equity$644M$688M$740M$573M$614M$660M$444M$468M

Implied volatility — last 90 days

40%70%101%131%161% Jun 07 — IV 75% · EM ±10.4%Jun 08 — IV 63% · EM ±8.3%Jun 09 — IV 76% · EM ±9.5%Jun 10 — IV 87% · EM ±10.2%Jun 11 — IV 74% · EM ±8.1%Jun 12 — IV 81% · EM ±8.3%Jun 15 — IV 104% · EM ±7.5%Jun 16 — IV 121% · EM ±7.2%Jun 19 — IV 44% · EM ±9.6%Jun 22 — IV 43% · EM ±9.0%Jun 23 — IV 45% · EM ±9.2%Jun 24 — IV 44% · EM ±8.9%Jun 25 — IV 42% · EM ±8.2%Jun 26 — IV 45% · EM ±8.6%Jun 29 — IV 50% · EM ±8.9%Jun 30 — IV 48% · EM ±8.3%Jul 01 — IV 43% · EM ±7.2%Jul 02 — IV 44% · EM ±7.0%Jul 03 — IV 45% · EM ±7.0%Jul 06 — IV 53% · EM ±7.3%Jul 07 — IV 57% · EM ±7.5%Jul 08 — IV 52% · EM ±6.6%Jul 10 — IV 53% · EM ±5.8%Jul 13 — IV 58% · EM ±4.9%Jul 16 — IV 161% · EM ±6.7%Jul 20 — IV 52% · EM ±12.3%Jul 21 — IV 51% · EM ±11.9%Jul 22 — IV 50% · EM ±11.5%Jul 23 — IV 46% · EM ±10.3%Jul 24 — IV 52% · EM ±11.4%Jul 27 — IV 53% · EM ±11.0%Jul 28 — IV 53% · EM ±10.9%Jul 29 — IV 52% · EM ±10.5%Jul 30 — IV 46% · EM ±9.0%Jul 31 — IV 51% · EM ±9.7%Aug 03 — IV 49% · EM ±8.7%Aug 04 — IV 41% · EM ±7.0%Aug 05 — IV 47% · EM ±7.9%Aug 06 — IV 50% · EM ±8.2%Aug 07 — IV 47% · EM ±7.4%Aug 10 — IV 48% · EM ±6.6%Aug 11 — IV 45% · EM ±5.9%Aug 12 — IV 45% · EM ±5.7%Aug 13 — IV 43% · EM ±5.0%Aug 14 — IV 43% · EM ±4.8%Aug 17 — IV 49% · EM ±4.1%Aug 18 — IV 49% · EM ±3.6%Aug 19 — IV 52% · EM ±3.1%Aug 20 — IV 60% · EM ±2.5%Aug 24 — IV 51% · EM ±10.7%Aug 25 — IV 45% · EM ±9.2%Aug 26 — IV 45% · EM ±9.0%Aug 27 — IV 44% · EM ±8.7%Aug 28 — IV 43% · EM ±8.2%Aug 31 — IV 42% · EM ±7.4%Sep 01 — IV 59% · EM ±10.1%Sep 02 — IV 55% · EM ±9.2%Sep 03 — IV 55% · EM ±8.9%Sep 04 — IV 59% · EM ±9.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in